{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:21:38Z","timestamp":1766514098756},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,8]],"date-time":"2015-03-08T00:00:00Z","timestamp":1425772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00399-015-0360-z","type":"journal-article","created":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T18:28:19Z","timestamp":1425752899000},"page":"148-154","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care"],"prefix":"10.1007","volume":"26","author":[{"given":"Andreas","family":"Goette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Benninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pittrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.D.","family":"Paar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"von Stritzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.F.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,8]]},"reference":[{"issue":"18","key":"360_CR1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370\u20132375","journal-title":"JAMA"},{"issue":"19","key":"360_CR2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al (2010) Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369\u20132429","journal-title":"Eur Heart J"},{"issue":"5 Suppl 1","key":"360_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amepre.2005.07.021","volume":"29","author":"AL Valderrama","year":"2005","unstructured":"Valderrama AL, Dunbar SB, Mensah GA (2005) Atrial fibrillation: public health implications. Am J Prev Med 29(5 Suppl 1):75\u201380","journal-title":"Am J Prev Med"},{"issue":"5","key":"360_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0002-9343(02)01253-6","volume":"113","author":"H Vidaillet","year":"2002","unstructured":"Vidaillet H, Granada JF, Chyou PH, Maassen K, Ortiz M, Pulido JN et al (2002) A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 113(5):365\u2013370","journal-title":"Am J Med"},{"issue":"23","key":"360_CR5","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107(23):2920\u20132925","journal-title":"Circulation"},{"issue":"4","key":"360_CR6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2006.03.051","volume":"48","author":"SN Singh","year":"2006","unstructured":"Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL et al (2006) Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 48(4):721\u2013730","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"360_CR7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","volume":"36","author":"P Dorian","year":"2000","unstructured":"Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM et al (2000) The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 36(4):1303\u20131309","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"360_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/107424840100600103","volume":"6","author":"CJ Howes","year":"2001","unstructured":"Howes CJ, Reid MC, Brandt C, Ruo B, Yerkey MW, Prasad B et al (2001) Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation. J Cardiovasc Pharmacol Ther 6(1):23\u201329","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"360_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcnurse.2003.12.002","volume":"3","author":"Y Kang","year":"2004","unstructured":"Kang Y, Bahler R (2004) Health-related quality of life in patients newly diagnosed with atrial fibrillation. Eur J Cardiovasc Nurs 3(1):71\u201376","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"7","key":"360_CR10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9149(00)01077-8","volume":"86","author":"M Paquette","year":"2000","unstructured":"Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C et al (2000) Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol 86(7):764\u2013768","journal-title":"Am J Cardiol"},{"issue":"3","key":"360_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/euhj.2001.2180","volume":"22","author":"MP Berg van den","year":"2001","unstructured":"van den Berg MP, Hassink RJ, Tuinenburg AE, van Sonderen EF, Lefrandt JD, de Kam PJ et al (2001) Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur Heart J 22(3):247\u2013253","journal-title":"Eur Heart J"},{"issue":"(","key":"360_CR12","first-page":"S","volume":"135","author":"W Kirch","year":"2010","unstructured":"Kirch W, Pittrow D, Bosch RF, Kohlhaussen A, Willich SN, Rosin L et al (2010) Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study. Dtsch Med Wochenschr 135(Suppl 2):S26\u2013S32","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"360_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1358\/dot.2006.42.2.925346","volume":"42","author":"KM Zareba","year":"2006","unstructured":"Zareba KM (2006) Dronedarone: a new antiarrhythmic agent. Drugs Today (Barc) 42(2):75\u201386","journal-title":"Drugs Today (Barc)"},{"key":"360_CR14","unstructured":"European Medicines Agency (EMA), MULTAQ 400\u00a0mg film-coated tablets (manufacturer: Sanofi Aventis). Summary of product characteristics. Last update 26 June 2014. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/001043\/human_med_001207.jsp&mid=WC0b01ac058001d124 . Accessed 11 Sept 2014"},{"issue":"Suppl","key":"360_CR15","first-page":"S","volume":"135","author":"J Schmitt","year":"2010","unstructured":"Schmitt J, Lewalter T, Pittrow D, Duray G, Goette A, Brachmann J et al (2010) Clinical profile of the new antiarrhythmic drug dronedarone. Dtsch Med Wochenschr 135(Suppl 2):S38\u2013S42","journal-title":"Dtsch Med Wochenschr"},{"issue":"22","key":"360_CR16","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2014.02.601","volume":"63","author":"L Friberg","year":"2014","unstructured":"Friberg L (2014) Safety of dronedarone in routine clinical care. J Am Coll Cardiol 63(22):2376\u20132384","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"360_CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10198-004-0264-z","volume":"6","author":"W Greiner","year":"2005","unstructured":"Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM (2005) Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6(2):124\u2013130","journal-title":"Eur J Health Econ"},{"issue":"3","key":"360_CR18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220\u2013233","journal-title":"Med Care"},{"key":"360_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-5-37","volume":"5","author":"X Badia","year":"2007","unstructured":"Badia X, Arribas F, Ormaetxe JM, Peinado R, de Los Terreros MS (2007) Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health Qual Life Outcomes 5:37","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"360_CR20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/europace\/eup421","volume":"12","author":"F Arribas","year":"2010","unstructured":"Arribas F, Ormaetxe JM, Peinado R, Perulero N, Ramirez P, Badia X (2010) Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace 12(3):364\u2013370","journal-title":"Europace"},{"issue":"5","key":"360_CR21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1185\/03007995.2011.563286","volume":"27","author":"H Bonnemeier","year":"2011","unstructured":"Bonnemeier H, Bosch RF, Kohlhaussen A, Rosin L, Willich SN, Pittrow D et al (2011) Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study. Curr Med Res Opin 27(5):995\u20131003","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"360_CR22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00392-011-0320-5","volume":"100","author":"T Meinertz","year":"2011","unstructured":"Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P (2011) Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol 100(10):897\u2013905","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"360_CR23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","volume":"360","author":"SH Hohnloser","year":"2009","unstructured":"Hohnloser SH, Crijns HJGM, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C et al (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360(7):668\u2013678","journal-title":"N Engl J Med"},{"issue":"3","key":"360_CR24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/europace\/euq012","volume":"12","author":"SS Pedersen","year":"2010","unstructured":"Pedersen SS, Kupper N (2010) Representing the patient perspective in the treatment of atrial fibrillation. Europace 12(3):305\u2013306","journal-title":"Europace"},{"issue":"10","key":"360_CR25","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/europace\/eus102","volume":"14","author":"AK Roalfe","year":"2012","unstructured":"Roalfe AK, Bryant TL, Davies MH, Hackett TG, Saba S, Fletcher K et al (2012) A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study. Europace 14(10):1420\u20131427","journal-title":"Europace"},{"key":"360_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group (1990) EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy 16:199\u2013208","journal-title":"Health Policy"},{"issue":"3","key":"360_CR27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00399-013-0283-5","volume":"24","author":"RF Bosch","year":"2013","unstructured":"Bosch RF, Pittrow D, Beltzer A, Kruck I, Kirch W, Kohlhaussen A et al (2013) Gender differences in patients with atrial fibrillation. Herzschrittmacherther Elektrophysiol 24(3):176\u2013183","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"7","key":"360_CR28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","volume":"16","author":"GJ Wynn","year":"2014","unstructured":"Wynn GJ, Todd DM, Webber M, Bonnett L, McShane J, Kirchhof P et al (2014) The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification. Europace 16(7):965\u2013972","journal-title":"Europace"},{"issue":"8","key":"360_CR29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jech.2003.008466","volume":"58","author":"M Delgado-Rodriguez","year":"2004","unstructured":"Delgado-Rodriguez M, Llorca J (2004) Bias. J Epidemiol Community Health 58(8):635\u2013641","journal-title":"J Epidemiol Community Health"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-015-0360-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-015-0360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-015-0360-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:14:24Z","timestamp":1551208464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-015-0360-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s00399-015-0360-z","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,8]]}}}